Explore the transformative impact of cell and gene therapies on the current standard of care for patients with autoimmune disease.
This webinar will delve into the rapid advancements in clinical development across a variety of disease states, highlighting unique challenges and how it compares with development in oncology. Learn how to enhance site readiness and patient centricity and discover the importance of early planning and data-driven decisions in the successful development of cell and gene therapies in this dynamic space.
Register for this webinar today to gain insights into the advancements and challenges of developing cell and gene therapies for autoimmune diseases.
Speakers
Erin Finot, MS, MBA, Vice President, Immuno-Oncology and Cell & Gene Therapy
Erin Finot, Vice President of Immuno-Oncology and Cell & Gene Therapy at IQVIA Biotech leads strategic efforts to ensure high-quality services and innovative solutions for biotech sponsors. With over 20 years of experience in global clinical research and drug development, Erin’s therapeutic expertise guides sponsors through the dynamic landscape of immuno-oncology and cell & gene therapies.
Message Presenter
Jessica Knight-Perry, MD, MSc, Senior Medical Director, Strategy Lead, Cell and Gene Therapy Center of Excellence
Jessica Knight-Perry is a board-certified pediatric hematologist/oncologist with additional expertise in hematopoietic stem cell transplantation and delivery of cell and gene therapies. In her current position, Jessica supports the development of cell and gene therapy assets for pharmaceutical and biotech companies.
Message Presenter
Emily Smith, Director, Therapeutic Strategy, Cell and Gene Therapy Center of Excellence
Emily Smith, a therapeutic strategy lead at IQVIA’s Cell and Gene Therapy Center of Excellence holds over 10 years of experience specializing in trial design and feasibility, focusing on non-oncology cell and gene therapy studies. She co-leads the Cell Therapy in Autoimmune Disease Working Group, collaborating with experts to develop comprehensive strategies for complex therapies.
Message PresenterWho Should Attend?
This webinar will appeal to clinical operations leaders with emerging biopharma (EBP), small pharma and biotech companies as well as those in the following fields:
- Clinical development/Clinical operations/Clinical research
- R&D
- CEO/COO
- Outsourcing
Seniority: Director level and above
What You Will Learn
During this webinar viewers will:
- Understand the challenges associated with these indications, the advantages of early planning and the data-driven decisions crucial for successful therapeutic advancements
- Utilize the knowledge gained from oncological studies to progress the advancement of cell therapies and help prepare clinical sites for the complexities of these trials
- Validate how a patient-focused approach benefits in the development and implementation of cell and gene therapies
- Discover how efficient operational models and expert cross-functional CAGT teams can reduce complexity and accelerate clinical trials
Xtalks Partner
IQVIA Biotech
IQVIA Biotech is a biotech-specialized CRO delivering flexible clinical development solutions for biotech and emerging biopharma companies. Our clinical solutions are built on 25 years of unmatched experience with therapeutically aligned expertise, uniquely designed to deliver full-service solutions on a global scale. Learn more at iqviabiotech.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account